| Active substance | Myostan |
|---|---|
| Release form | Pack (25 Pills) |
| Water Retention | Minimal to none |
| Hepatotoxicity | Moderate risk |
| Lab Test | Detection via specific blood tests for YK-11 metabolites |
| Also known as | YK11, YK-11 |
| Blood pressure | Can potentially elevate blood pressure |
| Trade name | Not commercially available under any trade name |
| Storage conditions | Store at room temperature away from moisture and direct sunlight |
| Chemical name | (17-alpha,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester |
| Formula | C25H34O6 |
| Substance class | Synthetic steroid |
| Main action | Selective Androgen Receptor Modulator (SARM) |
| Half-life | Approximately 6-10 hours |
| Dosage (medical) | Not medically approved or prescribed |
| Dosage (sports) | Typically 5-10 mg per day |
| Effects | Increases muscle mass, strength, and overall physical performance |
| Side effects | Potential liver toxicity, suppression of natural testosterone production, hair loss, joint pain |
| Use in sports | Commonly used as a performance-enhancing drug |
| Active ingredient, mg | 5 |
| 1 Pill, mg | 5 |
| Manufacturer | Driada Medical |
| Packing | Packaging (50 tablets) |
Reviews
There are no reviews yet.